Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Oberic
Rituximab–cyclophosphamide–dexamethasone Combination in the Management of Autoimmune Cytopenias Associated With Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
American Journal of Hematology
Hematology
Rituximab in Combination With High-Dose Methylprednisolone for the Treatment of Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Cost-Utility of Idelalisib in Combination With Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Breakthrough Therapy in Relapsed Chronic Lymphocytic Leukemia: The Combination of Idelalisib and Rituximab
Postdoc journal
Five Years of Experience With Rituximab Plus High-Dose Dexamethasone for Relapsed/Refractory Chronic Lymphocytic Leukemia
Archives of Medical Science
Medicine
Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies
Therapeutic Advances in Hematology
Hematology
Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine
Cancer Management and Research
Oncology
Chylothorax Associated With Chronic Lymphocytic Leukemia
Internal Medicine
Internal Medicine
Medicine
